CME

CME


Targeting IL-13 in Moderate to Severe Atopic Dermatitis: Forging a New Path to Improved Disease and Patient Outcomes

January 10, 2024

Guest: Terry Faleye, MPAS, PA-C

Guest: Jonathan I. Silverberg, MD, PhD, MPH


Atopic dermatitis (AD) significantly impacts physical, social, and psychological well-being. Recently, novel and more effective treatment options have been approved,